Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

1-Year Results from a Phase 2 Study to Determine Safety and Tolerability of Treating Patients with Light-Chain (AL) Amyloidosis with Cael-101, an Anti-Amyloid Monoclonal Antibody, Combined with Anti-Plasma Cell Dyscrasia

Jason Valent, Michaela Liedtke, Jeffrey A. Zonder, Mark Tulchinskiy, Chandrasekhar Udata, Girly Ramirez, Kate Szymaniak, Julia Catini, Candida Cristina Quarta

Blood (2022) 140 (Supplement 1): 10127–10128.

https://doi.org/10.1182/blood-2022-162597

Published: 2022

Journal Articles

Cardiac Amyloid Reaching for Extended Survival (CARES): Study Design of Two Placebo-Controlled, Double-Blind, Randomized, International Phase 3 Trials Assessing Cael-101 in Patients with Mayo Stage Iiia or Stage IIIb AL Amyloidosis

Ashutosh D. Wechalekar, John Silowsky, Eileen Daniel, Mark Harnett, Michael Spector, Susan B. Sobolov, Candida Cristina Quarta, Michael R. Kurman, Mark Tulchinskiy, Amit Bhattacharyya, Michaela Liedtke

Blood (2021) 138 (Supplement 1): 1673.

https://doi.org/10.1182/blood-2021-152488

Published: 2021